This Article Full Text Full Text (PDF) All Versions of this Article: 111/12/1537    most recent 01.CIR.0000159332.18585.B5v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rotmans, J. I. Articles by Stroes, E. S.G. Search for Related Content PubMed PubMed Citation Articles by Rotmans, J. I. Articles by Stroes, E. S.G. Related Collections Restenosis Animal models of human disease Peripheral vascular disease CV surgery: other

(Circulation. 2005;111:1537-1542.)
© 2005 American Heart Association, Inc.

Vascular Medicine

Sirolimus-Eluting Stents to Abolish Intimal Hyperplasia and Improve Flow in Porcine Arteriovenous Grafts

A 4-Week Follow-Up Study

Joris I. Rotmans, MD; Peter M.T. Pattynama, MD, PhD; Hence J.M. Verhagen, MD, PhD; Ichiro Hino, MD, PhD; Evelyn Velema, BSc; Gerard Pasterkamp, MD, PhD; Erik S.G. Stroes, MD, PhD

From the Experimental Cardiology Laboratory, University Medical Center (J.I.R., E.V., G.P.), and the Department of Vascular Surgery, University Medical Center (J.I.R., H.J.M.V.), Utrecht; the Department of Radiology, Erasmus MC, University Medical Center Rotterdam (P.M.T.P., I.H.); and the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.G.S.), the Netherlands.

Correspondence to Erik S.G. Stroes, MD, Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room F4.275, 1105 AZ, Amsterdam, The Netherlands. E-mail e.s.stroes{at}amc.uva.nl

Received June 14, 2004; revision received November 15, 2004; accepted November 19, 2004.

Background— The patency of arteriovenous (AV) expanded polytetrafluoroethylene (ePTFE) hemodialysis grafts is severely compromised by intimal hyperplasia (IH) at the venous anastomosis and in the venous outflow tract. We addressed the potential of primary placement of a sirolimus-eluting stent (SES) in a validated porcine model.

Methods and Results— In 25 pigs, ePTFE AV grafts were created bilaterally between the carotid artery and the jugular vein, whereupon a self-expandable nitinol stent (14 SESs and 11 bare-metal stents) was implanted over the venous anastomosis in 1 of the 2 grafts. After exclusion of technical failures and 1 unilateral occlusion, 16 pigs (9 SESs and 7 bare-metal stents) were included for further analysis. After 28 days, we measured graft flow and performed quantitative angiography. The pigs were then euthanized, and grafts with adjacent vessels were excised for histological analysis. Minimal luminal diameter was substantially larger in the SES group compared with unstented controls (5.9±0.2 versus 3.8±0.4 mm, respectively, P=0.01), which was accompanied by more prominent graft flow (SES, 1360±89 mL/min versus unstented, 861±83 mL/min, P=0.05). IH at the venous anastomosis was 77% less in the SES group compared with unstented controls (0.44±0.05 versus 1.92±0.5 mm², respectively, P=0.01), whereas IH increased markedly when bare-metal stents were used (5.7±1.4 mm², P=0.05).

Conclusions— SESs in the venous outflow of AV grafts significantly reduce IH and increase vessel diameter and graft flow compared with unstented grafts. These findings suggest that SESs have the potential to improve primary patency of AV grafts in hemodialysis patients.

Key Words: transplants • sirolimus • stents • hyperplasia • renal dialysis

This article has been cited by other articles:

				A. Yevzlin and A. Asif Stent Placement in Hemodialysis Access: Historical Lessons, the State of the Art and Future Directions Clin. J. Am. Soc. Nephrol., May 1, 2009; 4(5): 996 - 1008. [Abstract] [Full Text] [PDF]

				S. Misra, A. A. Fu, A. Puggioni, K. M. Karimi, J. N. Mandrekar, J. F. Glockner, L. A. Juncos, B. Anwer, A. M. McGuire, and D. Mukhopadhyay Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2219 - H2230. [Abstract] [Full Text] [PDF]

				Y. Wang, M. Krishnamoorthy, R. Banerjee, J. Zhang, S. Rudich, C. Holland, L. Arend, and P. Roy-Chaudhury Venous stenosis in a pig arteriovenous fistula model--anatomy, mechanisms and cellular phenotypes Nephrol. Dial. Transplant., February 1, 2008; 23(2): 525 - 533. [Abstract] [Full Text] [PDF]

				B. H. Lee, J. E. Lee, K. W. Lee, H. Y. Nam, H. J. Jeon, Y. J. Sung, J. S. Kim, H. J. Lim, J.-s. Park, J. Y. Ko, et al. Coating with paclitaxel improves graft survival in a porcine model of haemodialysis graft stenosis Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2800 - 2804. [Abstract] [Full Text] [PDF]

				C. M. Terry, D. K. Blumenthal, S. Sikharam, L. Li, T. Kuji, S. E. Kern, and A. K. Cheung Evaluation of histological techniques for quantifying haemodialysis arteriovenous (AV) graft hyperplasia Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3172 - 3179. [Abstract] [Full Text] [PDF]

				B. H. Lee, H. Y. Nam, T. Kwon, S. J. Kim, G. Y. Kwon, H. J. Jeon, H. J. Lim, W. K. Lee, J.-s. Park, J. Y. Ko, et al. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2432 - 2438. [Abstract] [Full Text] [PDF]

				P. Roy-Chaudhury, V. P. Sukhatme, and A. K. Cheung Hemodialysis Vascular Access Dysfunction: A Cellular and Molecular Viewpoint J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1112 - 1127. [Abstract] [Full Text] [PDF]